India recently loosened foreign direct investment (FDI) policy strictures geared towards Chinese FDI. It specifically allowed automatic approval of FDI from land bordering countries involving beneficial Chinese ownership of 10 percent or less (subject to sectoral FDI caps) and set a definitive approval timeline for FDI in critical sectors such...
Archives: Blog entries
December 10, 2025
Shein, Temu, and other Chinese online retailers like AliExpress (part of Alibaba Group) are a consumer’s dream. They give American, European, and other buyers access to an immense array of low-cost goods, a particularly appealing feature at a time when many are stressed by the rising cost of living. Politicians,...
October 4, 2025
Intel’s relationship with the United States (US) government since 2021 has experienced considerable ebbs and flows, though it seems to be on a high lately, obtaining a major investment from the US government as well as a slew of high-profile, major investments from leading high-tech firms like Nvidia. These public...
August 7, 2025
Apple has been a great success story in no small part because of China. China has been a huge market for United States (US) based smartphone giant (one of its largest markets along with the US), a key cog in its massive global supply chain, and a source of technology...
April 2, 2025
In fall 2024, the BIOSECURE Act, which blocked the United States (US)’s government’s use of goods and services from Chinese biotech companies, sailed through the US House of Representatives only to become stalled in the US Senate.[1] This is only one in a series of US government (USG) efforts to...
November 21, 2024
On September 9, the BIOSECURE Act, which this blog series has been covering since March, passed by a huge majority in the United States (US) House of Representatives. The essence of the act is the termination of direct and indirect US government dealings with five Chinese biotech companies (Complete Genomics,...
July 23, 2024
The most recent and prominent United States (US) attempt to limit cooperation with Chinese life science businesses has stalled, but is hardly dead. Current Speaker of the House Mike Johnson said he intends to have the BIOSECURE Act signed into law before the end of 2024.[1] Irrespective of the impasse,...
March 25, 2024
In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a...
January 5, 2024
The Belt and Road Initiative (BRI) has generated so much commentary that it is conceivable that if one printed out all the relevant pages and laid them end-to-end the length might approach that of all the railway track laid under the aegis of the BRI![i] Further commentary seems even more...
October 13, 2023
China, as you would expect, Belt and Road Initiative (BRI) participants and proponents, and even data support some of the positive sentiment in, if not the logic of, the previous blog in this four-part series on the future of the BRI, which highlighted numerous factors likely to continue propelling the...
